At the same time, the meds to treat those issues often lead to weight gain, which can discourage patients from staying on them
Retatrutide is still in clinical trials and not yet available
Not for human, veterinary, diagnostic, therapeutic or in-vivo use
Starting July 1, 2026, Medicare is launching a new pilot program called the Medicare GLP-1 Bridge that could make these medications available to eligible beneficiaries for just $50 a month
There is no listed drug interaction, no contraindication, and no specific warning about alcohol use
The island registered a 74.2% increase in e-prescriptions for glucagon-like peptide-1 agonists last year, followed by Vermont, Massachusetts, Washington and Wisconsin, according to Surescripts, which holds more than 95% of the e-prescription network market share in the U.S